SINDHU KURUP: Open Payments
NPI 1336795822 · GARFIELD HEIGHTS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 25 payments from 9 companies in 2025. Trend: 2023 $264 · 2024 $267 · 2025 $472
Food & beverage: $388Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $188 |
| Vanda Pharmaceuticals Inc. | 4 | $86 |
| Teva Pharmaceuticals USA, Inc. | 1 | $84 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Luye Pharma (USA) Ltd. | 1 | $22 |
| Alkermes, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Indivior Inc. | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: VRAYLAR, HETLIOZ, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, ARISTADA, CAPLYTA, FANAPT, SUBLOCADE.
Industry payments across OH — which companies pay providers there.
